Skip to main content

Table 5 Adverse events

From: Efficacy of an avocado-based Mediterranean diet on serum lipids for secondary prevention after ischemic stroke: a randomized phase 2 controlled pilot trial

 

Mediterranean diet n = 103

Low-fat diet n = 97

Any serious adverse event*

11 (10.7%)

11 (11.3%)

Recurrent stroke

2 (1.9%)

2 (2.1%)

Acute myocardial infarction or coronary revascularization

0 (0%)

1 (1.3%)

Other cardiovascular

5 (5.4%)

1 (1.3%)

Gastrointestinal

1 (0.9%)

1 (1.3%)

Infections

1 (0.9%)

2 (2.1%)

Neurological

1 (0.9%)

0 (0%)

Other serious adverse event

1(0.9%)

4 (4.4%)

Any nonserious adverse event

35 (34%)

27 (27.8%)

Gastrointestinal

20 (19.4%)

21 (21.6%)

Neurological

11 (10.7%)

3 (3.1%)

Infections

2 (1.9%)

2 (2.1%)

Cardiovascular

2 (1.9%)

0 (0%)

Other nonserious adverse event

0 (0%)

1 (1.3%)

  1. *Data are n (%). Additional information on adverse events is provided in the additional material